Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Histiocytoma, Malignant Fibrous × envafolimab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Histiocytoma, Malignant Fibrous 1 Dermatofibrosarcoma 1 Biliary Tract Neoplasms 1 Advanced or Metastatic Solid Tumors 1

Interventions

Ipilimumab 3 Specimen Handling 2 Radiotherapy 2 Radiation 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 CTLA-4 Antigen 2 Biopsy 2 talimogene laherparepvec 1 pazopanib 1 futibatinib 1 fludarabine 1 envafolimab 1 cabozantinib 1 aldesleukin 1 Ifosfamide 1 Erlotinib Hydrochloride 1 Doxorubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04480502 2024-05-17

ENVASARC

Tracon Pharmaceuticals Inc.

Phase 2 Active not recruiting

Sarcoma, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡